Muscle cyclo-oxygenase-2 pathway contributes to the exaggerated muscle mechanoreflex in rats with congestive heart failure
Related Experiment Video
Updated: May 23, 2026

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
Ariel Morales1, Wei Gao, Jian Lu
1Heart & Vascular Institute, The Pennsylvania State University College of Medicine, Hershey, PA, USA.
Abstract:
Cyclo-oxygenase (COX) enzymes are responsible for the formation from arachidonic acid of prostaglandins, among other metabolites. Prior studies have suggested that inhibition of the COX pathway attenuates the responses of sympathetic nerve activity and blood pressure during static muscle contraction. Static muscle contraction activates the exercise pressor reflex, which in turn increases sympathetic nerve activity and blood pressure. Also, COX products contribute to exaggeration of the exercise pressor reflex in heart failure (HF). This dysfunction of the exercise pressor reflex has previously been shown to be mediated primarily by muscle mechanoreflex overactivity. It is well known that COX-1 and COX-2 are two isoforms of the enzyme that lead to formation of these important biological mediators involved in the muscle reflex. Thus, in the present study, we determined whether the COX-1 and/or COX-2 pathway contribute(s) to the augmented mechanoreflex activity in HF. First, Western blot analysis was employed to examine protein expression of COX-1 and COX-2 in skeletal muscle tissue of control rats and rats with HF induced by myocardial infarction. Our data show that there is no significant difference in COX-1 expression in both experimental groups. However, COX-2 displays significant overexpression in rats with HF compared with control rats (optical density 1.06 ± 0.05 in control and 1.6 ± 0.05 in HF, P < 0.05 versus control). Second, the mechanoreflex was evoked by passive tendon stretch, and the reflex sympathetic and pressor responses to muscle stretch were examined after COX-1 and COX-2 inhibitors (FR-122047 and SC-236) were individually injected into the arterial blood supply of the hindlimb muscles. The results demonstrate that the stretch-evoked reflex responses in rats with HF were significantly attenuated by administration of SC-236, but not by FR-122047, i.e. renal sympathetic nerve activity and mean arterial pressure responses evoked by 0.5 kg of muscle tension were 52.3 ± 8.9% and 19 ± 1.4 mmHg, respectively, in control conditions and 26.4 ± 5.6% and 5.7 ± 1.6 mmHg (P < 0.05 versus control group) after 0.25 mg kg(-1) of SC-236. Muscle stretch-evoked renal sympathetic nerve activity and mean arterial pressure responses were 51.8 ± 8.2% and 18.7 ± 1.2 mmHg, respectively, in control conditions and 48.3 ± 5.3% and 17.5 ± 1.9 mmHg (P > 0.05 versus control group) after 1.0 mg kg(-1) of FR-122047. Accordingly, the results obtained from this study support our hypothesis that heightened COX-2 expression within the hindlimb muscles contributes to the exaggerated muscle mechanoreflex in congestive HF.
Insights
Heart failure (HF) exacerbates the muscle mechanoreflex, a response involving cyclo-oxygenase-2 (COX-2). Inhibiting COX-2, but not COX-1, in rats with HF significantly reduced this augmented reflex, indicating COX-2
Area of Science:
- Cardiovascular Physiology
- Skeletal Muscle Reflexes
- Enzyme Function and Regulation
Background:
- Cyclo-oxygenase (COX) enzymes produce prostaglandins, influencing sympathetic nerve activity and blood pressure during muscle contraction.
- The exercise pressor reflex, activated by static muscle contraction, increases sympathetic nerve activity and blood pressure.
- COX products can exaggerate the exercise pressor reflex in heart failure (HF), primarily through muscle mechanoreflex overactivity.
Purpose of the Study:
- To investigate the contribution of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2) pathways to augmented muscle mechanoreflex activity in heart failure (HF).
- To determine if COX-2 is overexpressed in skeletal muscle of rats with HF.
- To assess the effect of COX-1 and COX-2 inhibition on the muscle mechanoreflex in HF.
Main Methods:
- Western blot analysis to compare COX-1 and COX-2 protein expression in hindlimb skeletal muscle of control rats and rats with experimentally induced HF.
- Evoking the muscle mechanoreflex via passive tendon stretch in rats.
- Administering selective COX-1 (FR-122047) and COX-2 (SC-236) inhibitors via arterial injection to assess their impact on reflex sympathetic and pressor responses.
Main Results:
- Skeletal muscle COX-2 expression was significantly upregulated in rats with HF compared to controls.
- COX-1 expression showed no significant difference between HF and control rats.
- Selective inhibition of COX-2 with SC-236 significantly attenuated the exaggerated muscle mechanoreflex (renal sympathetic nerve activity and mean arterial pressure) in rats with HF.
- Inhibition of COX-1 with FR-122047 did not significantly alter the mechanoreflex responses in rats with HF.
Conclusions:
- Heightened expression of COX-2 within hindlimb muscles contributes to the exaggerated muscle mechanoreflex observed in congestive heart failure (HF).
- Targeting the COX-2 pathway may represent a therapeutic strategy for modulating aberrant muscle reflex activity in HF patients.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Nitric Oxide Signaling Pathway
Pathophysiology of Cardiac Performance
Cardiomyopathy V: Interprofessional Care
